Hairy Cell Leukemia (HCL)

Also known as: Leukemia, Hairy Cell / Hairy cell leukaemia / Hairy Cell Leukemia / Leukemias, Hairy Cell / Leukemic reticuloendotheliosis / Leukaemic reticuloendotheliosis

DrugDrug NameDrug Description
DB00242CladribineAn antineoplastic agent used in the treatment of lymphoproliferative diseases including hairy-cell leukemia. [PubChem]
DB00105Interferon Alfa-2b, RecombinantInterferon alpha 2b (human leukocyte clone hif-sn 206 protein moiety reduced). A type I interferon consisting of 165 amino acid residues with arginine in position 23. This protein is produced by recombinant DNA technology and resembles interferon secreted by leukocytes. It is used extensively as an antiviral or antineoplastic agent.
DB00552PentostatinA potent inhibitor of adenosine deaminase. The drug is effective in the treatment of many lymphoproliferative malignancies, particularly hairy-cell leukemia. It is also synergistic with some other antineoplastic agents and has immunosuppressive activity. [PubChem]
DrugDrug NamePhaseStatusCount
DB12688Moxetumomab Pasudotox1Completed1
DB12121Entospletinib1 / 2Recruiting1
DB08935Obinutuzumab1 / 2Recruiting1
DB08881Vemurafenib2Active Not Recruiting1
DB00242Cladribine2 / 3Recruiting1
DB00125L-Arginine2 / 3Recruiting1
DB12688Moxetumomab Pasudotox3Active Not Recruiting1